Posted by Michael Wonder on 20 Feb 2020
Outcomes from the November 2019 PTAC meeting
20 February 2020 - PHARMAC has published a record of the November 2019 Pharmacology and Therapeutics Advisory Committee meeting.
The Pharmacology and Therapeutics Advisory Committee (PTAC) did not consider a submission for a new medicine.
- Adalimumab & infliximab - restriction change
- Tacrolimus - new indication
- Sirolimus - new indication
- Everolimus & sirolimus - new indication
- Medicines for multiple sclerosis - restriction change
- Cladribine - new indication
- Adalimumab & etanercept - restriction change
- Adalimumab - restriction change
